DJIA 18,030.21 0.00 0.00%
NASDAQ 4,773.47 0.00 0.00%
S&P 500 2,081.88 0.00 0.00%
market minute promo

Amicus Therapeutics, Inc. (NASDAQ: FOLD)

7.94 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

FOLD $7.94 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.88
Previous Close $7.94
Daily Range $7.83 - $8.08
52-Week Range $1.77 - $8.79
Market Cap $629.8M
P/E Ratio -8.95
Dividend (Yield) $0.00 (0.0%)
Volume 465,252
Average Daily Volume 2,309,747
Current FY EPS -$0.87





Amicus Therapeutics, Inc. (FOLD) Description

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. Website:

News & Commentary Rss Feed

This Tiny Biotech Worries Sanofi and Shire, and Vexes GlaxoSmithKline

Amicus Therapeutics plans to file for EU approval of a treatment for Fabry Disease that could challenge Sanofi and Shire.

Amicus: Multiple Catalysts For Promising Fabry Treatment

Trade-Ideas: Amicus Therapeutics (FOLD) Is Today's "Perilous Reversal" Stock

NPS Pharmaceuticals Spikes 19% Amid Shire Bid Report

These 4 Biotech Stocks Have Been On Fire

3 Large Cap Biotech Stocks That Could Pay Dividends, But Won't

Gilead Sciences, Celgene, and Biogen all have rock-solid financials, but none are likely to pay a dividend anytime soon.

Will Amicus Therapeutics (FOLD) Continue to Surge Higher? - Tale of the Tape

Amicus Therapeutics (FOLD) Weak On High Volume

Warren Buffett Pick CBI Tumbles On Rating Downgrade

Health Care Sector Update for 11/19/2014: MNK, FOLD

See More FOLD News...

FOLD's Top Competitors

FOLD $7.94 (0.00%)
Current stock: FOLD
AMGN $160.67 (0.00%)
Current stock: AMGN
GILD $91.15 (-0.15%)
Current stock: GILD
BIIB $340.89 (0.00%)
Current stock: BIIB